Toxic Shock Syndrome
📧 Sign up to get email alerts when something new happens for Toxic Shock Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
A recruiting clinical trial sponsored by CNRS France is investigating how internal menstrual protections influence immunity and vaginal micr…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study [Phase 2]
A completed Phase 2 pediatric pilot study assessing the efficacy of intravenous immunoglobulins for Toxic Shock Syndrome. The update reports…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Prodromes of Menstrual Staphylococcal Toxic Shock
A clinical trial investigating prodromes of menstrual Staphylococcal toxic shock syndrome is currently recruiting, sponsored by Hospices Civ…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults [Phase 2]
Phase 2 clinical trial of the BioMed rTSST-1 variant vaccine in healthy adults has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2021-05-03Clinical Trial Update: Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children [Phase 4]
A Phase 4 study evaluating intravenous immunoglobulins for toxic shock syndromes in children was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial [Phase 1]
This document reports an amendment to a Phase 1 trial and completion of a study evaluating an rTSST-1 variant vaccine for toxic shock syndro…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: rTSST-1 Variant Vaccine Phase 1 First-in-man Trail [Phase 1]
This update reports the completion of a Phase 1 first-in-man trial of an rTSST-1 variant vaccine intended to prevent toxic shock syndrome an…